Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)
InSightec
InSightec
InSightec
Telix Pharmaceuticals (Innovations) Pty Limited
CNS Pharmaceuticals, Inc.
Black Diamond Therapeutics, Inc.
NaviFUS Corporation
Novelwise Pharmaceutical Corporation
Iambic Therapeutics, Inc
Tango Therapeutics, Inc.
NaviFUS Corporation
NaviFUS Corporation
NaviFUS Corporation
Stemline Therapeutics, Inc.
Pfizer
Hoffmann-La Roche
Bristol-Myers Squibb
Eli Lilly and Company
InSightec
Aesculap AG
BioNTech SE
Hoffmann-La Roche
Eli Lilly and Company
Neonc Technologies, Inc.
Integra LifeSciences Corporation
Exelixis
Hoffmann-La Roche
Exelixis
Monteris Medical
Telix Pharmaceuticals (Innovations) Pty Limited
GT Medical Technologies, Inc.
AstraZeneca
Sapience Therapeutics
Guerbet
Adela, Inc